产品介绍
| 产品名称 Anti-CKAP4抗体[EPR25713-62] (BSA and Azide free) 参阅全部 CKAP4 一抗 描述 兔单克隆抗体[EPR25713-62] to CKAP4 - BSA and Azide free 宿主 Rabbit 经测试应用 适用于: ICC/IF, IP, Flow Cyt (Intra), IHC-P, WBmore details 种属反应性 与反应: Mouse, Rat, Human 免疫原 Recombinant fragment. This information is proprietary to Abcam and/or its suppliers. 阳性对照 WB: Whole cell lysates: HeLa (human cervix adenocarcinoma epithelial cell) transfected with scrambled siRNA, HeLa transfected with siRNA targeting cytoskeleton-associated protein 4, Caco-2, 3T3-L1, NIH/3T3, PC-12, A549, ; Tissue lysates: mouse pancreas cancer, human: colon, colon cancer, lung cancer, low expression skeletal muscle. IHC-P: Tissues: Human: cerebral cortex, lung cancer, colon; Mouse and rat cerebral cortex. ICC/IF: HeLa, NIH/3T3. Flow cyt. Intr.: HeLa, NIH/3T3. IP: HeLa, NIH/3T3. 常规说明 ab302540 is a carrier free version of ab302539. This antibody clone is manufactured by Abcam. If you require a custom buffer formulation or conjugation for your experiments, please contact orders@abcam.com. Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. The carrier-free buffer and high concentration allow for increased conjugation efficiency. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications. Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with <1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold. This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc. This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free production For more information see here. Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents. |